Then, we explored the molecular mechanism by which SMOC2 regulates MYO1C and the possibility of SMOC2 intervention for the treatment of RA in a collagen-induced arthritis (CIA) rat model. The gene discussed is MYO1C; the disease is rheumatoid arthritis.